Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 728,846,848
  • Shares Outstanding, K 949,316
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • EBIT $ 13,467 M
  • EBITDA $ 14,994 M
  • 60-Month Beta 0.41
  • Price/Sales 21.07
  • Price/Cash Flow 99.33
  • Price/Book 50.22

Options Overview Details

View History
  • Implied Volatility 32.33% ( -7.15%)
  • Historical Volatility 32.28%
  • IV Percentile 55%
  • IV Rank 30.25%
  • IV High 55.08% on 08/05/24
  • IV Low 22.46% on 06/28/24
  • Put/Call Vol Ratio 0.56
  • Today's Volume 78,580
  • Volume Avg (30-Day) 40,098
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 362,346
  • Open Int (30-Day) 349,915

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 5.49
  • Number of Estimates 8
  • High Estimate 5.58
  • Low Estimate 5.37
  • Prior Year 2.49
  • Growth Rate Est. (year over year) +120.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
735.00 +4.46%
on 11/21/24
846.46 -9.30%
on 12/04/24
+14.35 (+1.90%)
since 11/20/24
3-Month
711.40 +7.92%
on 11/18/24
939.30 -18.26%
on 09/25/24
-153.73 (-16.68%)
since 09/20/24
52-Week
567.02 +35.40%
on 12/21/23
972.53 -21.06%
on 08/22/24
+197.55 (+34.65%)
since 12/20/23

Most Recent Stories

More News
2 Dividend-Growth Stocks That Billionaire Izzy Englander Loves

Investing in dividend stocks is a great strategy for many reasons, including the potential they offer you to significantly boost your long-term returns by automatically reinvesting their payouts. Furthermore,...

MSFT : 436.60 (-0.10%)
LLY : 767.76 (+1.35%)
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.

NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a tailspin this week. According to data compiled by S&P Global Market Intelligence,...

VKTX : 42.25 (+1.83%)
NVO : 85.00 (-17.83%)
MRK : 98.05 (-1.48%)
LLY : 767.76 (+1.35%)
Stocks Rally on Dovish PCE Inflation Report

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.23%. March E-mini S&P...

MSTR : 364.20 (+11.56%)
MARA : 19.96 (-2.01%)
NVDA : 134.70 (+3.08%)
$SPX : 5,930.85 (+1.09%)
MU : 90.12 (+3.48%)
NKE : 76.94 (-0.21%)
$IUXX : 21,289.15 (+0.85%)
NQH25 : 21,566.50s (+0.88%)
COIN : 278.71 (+1.75%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
OXY : 47.13 (+3.90%)
Novo Nordisk Heads For Worst Day In 22 Years As New Obesity Drug Underwhelms: Retail Brushes Off ‘Super Silly’ Drop

On the analyst front, Citi and UBS both described Novo’s readout as favorable for Eli Lilly.

VKTX : 42.25 (+1.83%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
AMGN : 263.38 (+0.84%)
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.

VKTX : 42.25 (+1.83%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
Stocks Regain Footing on Dovish PCE Inflation Report

The S&P 500 Index ($SPX ) (SPY ) today is up +1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. March E-mini S&P futures (ESH25...

MSTR : 364.20 (+11.56%)
MARA : 19.96 (-2.01%)
$SPX : 5,930.85 (+1.09%)
NKE : 76.94 (-0.21%)
$IUXX : 21,289.15 (+0.85%)
NQH25 : 21,566.50s (+0.88%)
COIN : 278.71 (+1.75%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
OXY : 47.13 (+3.90%)
ESH25 : 6,001.75s (+1.14%)
X : 30.14 (-4.98%)
Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown

The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. March E-mini S&P futures...

MARA : 19.96 (-2.01%)
MSTR : 364.20 (+11.56%)
$SPX : 5,930.85 (+1.09%)
NKE : 76.94 (-0.21%)
$IUXX : 21,289.15 (+0.85%)
NQH25 : 21,566.50s (+0.88%)
COIN : 278.71 (+1.75%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
OXY : 47.13 (+3.90%)
ESH25 : 6,001.75s (+1.14%)
X : 30.14 (-4.98%)
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow vast...

LLY : 767.76 (+1.35%)
BMY : 57.33 (+1.83%)
This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

NVO : 85.00 (-17.83%)
HIMS : 26.20 (-0.61%)
LLY : 767.76 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 841.94
2nd Resistance Point 826.65
1st Resistance Point 797.20
Last Price 767.76
1st Support Level 752.46
2nd Support Level 737.17
3rd Support Level 707.72

See More

52-Week High 972.53
Fibonacci 61.8% 817.63
Fibonacci 50% 769.78
Last Price 767.76
Fibonacci 38.2% 721.92
52-Week Low 567.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar